Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 5/2020

01-10-2020 | Hepatitis | Case Report

Development of anti-centromere antibody-positive autoimmune hepatitis after childbirth

Authors: Mitsunobu Saito, Noriyuki Akutsu, Yasunao Numata, Keisuke Ishigami, Shigeru Sasaki, Hiroshi Nakase

Published in: Clinical Journal of Gastroenterology | Issue 5/2020

Login to get access

Abstract

This is the first case involving the development of anti-centromere antibody (ACA)-positive autoimmune hepatitis (AIH) after childbirth that triggered nailfold bleeding. A 32-year-old woman visited a dermatologist presenting with nailfold bleeding 6 months after the delivery of her second baby. Blood tests revealed liver dysfunction, and she was admitted to our hospital. Tests for hepatitis virus, antinuclear antibody, and anti-mitochondrial antibody were negative. She had no history of alcohol consumption or oral medication. Because of nailfold bleeding, we performed tests for ACA, anti-Scl-70 antibody, anti-RNA polymerase III antibody, and anti-U1 RNP antibodies; only ACA was positive. A liver biopsy was performed for the diagnosis of liver dysfunction. Histological examination of the liver biopsy specimen showed moderate infiltration of inflammatory cells, interface hepatitis, bridging fibrosis, and bile duct injury. The AIH international score was 17, and thus, we diagnosed AIH. Oral prednisolone (PSL) 0.6 mg/day/body weight was initiated. Two weeks post-treatment, the liver enzyme levels normalized and the nailfold bleeding disappeared. In case of nailfold bleeding complicated with liver dysfunction post-childbirth, ACA-positive AIH should be considered as a differential diagnosis.
Literature
2.
go back to reference Manns MP, Czaja AJ, Gorham JD, et al. Diagnosis and management of autoimmune hepatitis. Hepatology. 2010;51:2193–213.CrossRef Manns MP, Czaja AJ, Gorham JD, et al. Diagnosis and management of autoimmune hepatitis. Hepatology. 2010;51:2193–213.CrossRef
3.
go back to reference Sato S, Takehara K, Soma Y, et al. Diagnostic significance of nailfold bleeding in scleroderma spectrum disorders. J Am Acad Dermatol. 1993;28:198–203.CrossRef Sato S, Takehara K, Soma Y, et al. Diagnostic significance of nailfold bleeding in scleroderma spectrum disorders. J Am Acad Dermatol. 1993;28:198–203.CrossRef
4.
go back to reference Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48:169–76.CrossRef Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48:169–76.CrossRef
5.
go back to reference Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929–38.CrossRef Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929–38.CrossRef
6.
go back to reference Takahashi A, Arinaga-Hino T, Ohira H, et al. Autoimmune hepatitis in Japan: trends in a nationwide survey. J Gastroenterol. 2017;52:631–40.CrossRef Takahashi A, Arinaga-Hino T, Ohira H, et al. Autoimmune hepatitis in Japan: trends in a nationwide survey. J Gastroenterol. 2017;52:631–40.CrossRef
7.
go back to reference Nguyen Canh H, Harada K, Ouchi H, et al. Acute presentation of autoimmune hepatitis: a multicentre study with detailed histological evaluation in a large cohort of patients. J Clin Pathol. 2017;70:961–9.CrossRef Nguyen Canh H, Harada K, Ouchi H, et al. Acute presentation of autoimmune hepatitis: a multicentre study with detailed histological evaluation in a large cohort of patients. J Clin Pathol. 2017;70:961–9.CrossRef
8.
go back to reference Perosa F, Prete M, Di Lernia G, et al. Anti-centromere protein A antibodies in systemic sclerosis: significance and origin. Autoimmun Rev. 2016;15:102–9.CrossRef Perosa F, Prete M, Di Lernia G, et al. Anti-centromere protein A antibodies in systemic sclerosis: significance and origin. Autoimmun Rev. 2016;15:102–9.CrossRef
9.
go back to reference Baer AN, Medrano L, McAdams-DeMarco M, et al. Anti-centromere antibodies are associated with more severe exocrine glandular dysfunction in Sjögren’s syndrome: analysis of the Sjögren’s International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken). 2016;68:1554–9.CrossRef Baer AN, Medrano L, McAdams-DeMarco M, et al. Anti-centromere antibodies are associated with more severe exocrine glandular dysfunction in Sjögren’s syndrome: analysis of the Sjögren’s International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken). 2016;68:1554–9.CrossRef
10.
go back to reference Liberal R, Grant CR, Sakkas L, et al. Diagnostic and clinical significance of anti-centromere antibodies in primary biliary cirrhosis. Clin Res Hepatol Gastroenterol. 2013;37:572–85.CrossRef Liberal R, Grant CR, Sakkas L, et al. Diagnostic and clinical significance of anti-centromere antibodies in primary biliary cirrhosis. Clin Res Hepatol Gastroenterol. 2013;37:572–85.CrossRef
11.
go back to reference Saito H, Takahashi A, Abe K, et al. Autoantibodies by line immunoassay in patients with primary biliary cirrhosis. Fukushima J Med Sci. 2012;58:107–16.CrossRef Saito H, Takahashi A, Abe K, et al. Autoantibodies by line immunoassay in patients with primary biliary cirrhosis. Fukushima J Med Sci. 2012;58:107–16.CrossRef
12.
go back to reference Monoe K, Takahashi A, Abe K, et al. Evaluation of nail fold capillaroscopy findings in patients with primary biliary cirrhosis. Hepatol Res. 2014;44:E129–E136136.CrossRef Monoe K, Takahashi A, Abe K, et al. Evaluation of nail fold capillaroscopy findings in patients with primary biliary cirrhosis. Hepatol Res. 2014;44:E129–E136136.CrossRef
13.
go back to reference Izumi Y, Kaneko A, Oku K, et al. Development of liver dysfunction after delivery is possibly due to postpartum autoimmune hepatitis. A report of three cases. J Intern Med. 2002;252:361–7.CrossRef Izumi Y, Kaneko A, Oku K, et al. Development of liver dysfunction after delivery is possibly due to postpartum autoimmune hepatitis. A report of three cases. J Intern Med. 2002;252:361–7.CrossRef
14.
go back to reference Samuel D, Riordan S, Strasser S, et al. Severe autoimmune hepatitis first presenting in the early postpartum period. Clin Gastroenterol Hepatol. 2004;2:622–4.CrossRef Samuel D, Riordan S, Strasser S, et al. Severe autoimmune hepatitis first presenting in the early postpartum period. Clin Gastroenterol Hepatol. 2004;2:622–4.CrossRef
15.
go back to reference Efe C, Purnak T, Ozaslan E. Autoimmune hepatitis in the postpartum period. Clin Res Hepatol Gastroenterol. 2012;36:391–3.CrossRef Efe C, Purnak T, Ozaslan E. Autoimmune hepatitis in the postpartum period. Clin Res Hepatol Gastroenterol. 2012;36:391–3.CrossRef
16.
go back to reference Longhi MS, Ma Y, Bogdanos DP, et al. Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease. J Hepatol. 2004;41:31–7.CrossRef Longhi MS, Ma Y, Bogdanos DP, et al. Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease. J Hepatol. 2004;41:31–7.CrossRef
17.
go back to reference Grønbæk L, Vilstrup H, Pedersen L, et al. Family occurrence of autoimmune hepatitis: a Danish nationwide registry-based cohort study. J Hepatol. 2018;69:873–7.CrossRef Grønbæk L, Vilstrup H, Pedersen L, et al. Family occurrence of autoimmune hepatitis: a Danish nationwide registry-based cohort study. J Hepatol. 2018;69:873–7.CrossRef
18.
go back to reference Yoshizawa K, Ota M, Katsuyama Y, et al. Genetic analysis of the HLA region of Japanese patients with type 1 autoimmune hepatitis. J Hepatol. 2005;42:578–84.CrossRef Yoshizawa K, Ota M, Katsuyama Y, et al. Genetic analysis of the HLA region of Japanese patients with type 1 autoimmune hepatitis. J Hepatol. 2005;42:578–84.CrossRef
19.
go back to reference Kayser K, Paul K, Feist D, et al. Alteration of the lung parenchyma associated with autoimmune hepatitis. Virchows Arch A Pathol Anat Histopathol. 1991;419:153–7.CrossRef Kayser K, Paul K, Feist D, et al. Alteration of the lung parenchyma associated with autoimmune hepatitis. Virchows Arch A Pathol Anat Histopathol. 1991;419:153–7.CrossRef
20.
go back to reference Koulaouzidis A, Karagiannidis A, Prados S, et al. Lymphocytic interstitial pneumonitis (LIP)-the liver and the lung. Ann Hepatol. 2006;5:170–1.CrossRef Koulaouzidis A, Karagiannidis A, Prados S, et al. Lymphocytic interstitial pneumonitis (LIP)-the liver and the lung. Ann Hepatol. 2006;5:170–1.CrossRef
21.
go back to reference Zold E, Bodolay E, Dezső B, et al. Mixed connective tissue disease associated with autoimmune hepatitis and pulmonary fibrosis. Isr Med Assoc J. 2014;16:733–4. Zold E, Bodolay E, Dezső B, et al. Mixed connective tissue disease associated with autoimmune hepatitis and pulmonary fibrosis. Isr Med Assoc J. 2014;16:733–4.
Metadata
Title
Development of anti-centromere antibody-positive autoimmune hepatitis after childbirth
Authors
Mitsunobu Saito
Noriyuki Akutsu
Yasunao Numata
Keisuke Ishigami
Shigeru Sasaki
Hiroshi Nakase
Publication date
01-10-2020
Publisher
Springer Singapore
Published in
Clinical Journal of Gastroenterology / Issue 5/2020
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-020-01092-w

Other articles of this Issue 5/2020

Clinical Journal of Gastroenterology 5/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.